Szekeres-Bartho J, Hadnagy J, Csernus V, Balázs L, Magyarlaki T, Pacsa A S
Am J Reprod Immunol Microbiol. 1985 Jan;7(1):22-6. doi: 10.1111/j.1600-0897.1985.tb00258.x.
Recently we have shown that lymphocytes of pregnant women with threatened preterm delivery (risk group) exerted significantly higher cytotoxic activity to human embryonic fibroblast (HEF) cells than those of healthy pregnant women. The purpose of this study was to get information on the mechanism of this cytotoxicity. The possibility of prior sensitization to embryonic antigen was excluded, since no difference could be demonstrated between cytotoxic activity of lymphocytes obtained from women with two or more previous pregnancies and that of lymphocytes from never-pregnant women. For determining the effector cell type responsible for cytotoxicity, lymphocytes of 50 healthy pregnant women and those of 50 risk patients were tested in different cytotoxicity tests using HEF and K-562 target cells. The proportion of NK cells among lymphocytes was determined by counting large granular lymphocytes (LGL), IgG Fc receptor bearing cells, and cells positively stained by NK specific monoclonal antibody. Though no difference in the proportion of NK cells between the two groups was found, risk patients' lymphocytes were significantly more cytotoxic to K-562 target cells than those of healthy pregnant women. Investigations at the single-cell level made it obvious that this higher cytotoxic activity originated from increased target cell lysing ability of their lymphocytes, while their conjugating capacity did not differ significantly from that of lymphocytes obtained from healthy pregnant women.(ABSTRACT TRUNCATED AT 250 WORDS)
最近我们发现,有早产风险的孕妇(风险组)的淋巴细胞对人胚胎成纤维细胞(HEF)的细胞毒性活性明显高于健康孕妇的淋巴细胞。本研究的目的是了解这种细胞毒性的机制。由于在有两次或更多次既往妊娠的妇女中获得的淋巴细胞的细胞毒性活性与从未怀孕妇女的淋巴细胞的细胞毒性活性之间没有差异,因此排除了先前对胚胎抗原致敏的可能性。为了确定负责细胞毒性的效应细胞类型,使用HEF和K-562靶细胞在不同的细胞毒性试验中检测了50名健康孕妇和50名风险患者的淋巴细胞。通过计数大颗粒淋巴细胞(LGL)、携带IgG Fc受体的细胞以及被NK特异性单克隆抗体阳性染色的细胞来确定淋巴细胞中NK细胞的比例。虽然两组之间NK细胞的比例没有差异,但风险患者的淋巴细胞对K-562靶细胞的细胞毒性明显高于健康孕妇。单细胞水平的研究表明,这种较高的细胞毒性活性源于其淋巴细胞的靶细胞裂解能力增强,而其结合能力与从健康孕妇获得的淋巴细胞的结合能力没有显著差异。(摘要截断于250字)